ArticleFrontiers in medicine2025
Deep learning-assisted widefield endothelial imaging in Descemet membrane endothelial keratoplasty.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence in corneal endothelial disease and endothelial keratoplasty: current evidence, clinical readiness, and future directions.Frontiers in ophthalmology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Significant endothelial cell density (ECD) losses in Descemet membrane endothelial keratoplasty (DMEK) can precipitate graft failure. Currently, clinical practice only evaluates the central corneal endothelium and not the paracentral or peripheral cornea. Here, we evaluate a deep learning (DL) algorithm for automated image quality assessment and detection of low corneal ECD in widefield specular microscopy (WFSM) images following DMEK, at central, paracentral and peripheral regions. Methods: Prospective observational study in eyes with clear, stable DMEKs. WFSM imaging (CEM-530; Nidek, Japan) performed at a baseline visit (mean of 23 months post-DMEK) and 6 months after. Images at 15 locations were captured; 1 central, 8 paracentral, and 6 peripheral. Image quality and corneal endothelial cell parameters including ECD were assessed. SqueezeNet architecture was employed for binary and multi-class automated image quality and low ECD detection (threshold set at < 1,000 cells/mm Results: DMEK was performed in 53 eyes (43 subjects, mean age 67.4 ± 10.1 years) with Fuchs endothelial corneal dystrophy (FECD) (71.7%; 38 eyes) and pseudophakic bullous keratopathy (PBK) (28.3%; 15 eyes). The DL classification models were trained and validated on 1,362 images, achieving AUCs of 0.979 (binary image quality), 0.907 (multi-class image quality) and 0.980 (low ECD detection). WFSM imaging was able to detect both central ECD loss (1,709 vs. 1,555 cells/mm Conclusion: Serial WFSM was able to image a larger area of the endothelium in eyes with DMEK. Our DL model was a useful adjunct that analysed the large number of specular microscopy images to identify scans of adequate quality and ECD based on pre-defined thresholds. This approach may support the use of DL-assisted WFSM for early detection of ECD loss which may aid in monitoring endothelial health and graft survival following DMEK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.